Tenax Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Tenax Therapeutics

16/11/2021 14:34

* Tenax Therapeutics Inc  TENX.OQ  reported a quarterly adjusted
loss of 15 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 13 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Tenax Therapeutics Inc's reported EPS for the quarter was a
loss of 15 cents​.
* The mean earnings estimate of analysts had fallen by about 4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Tenax Therapeutics Inc shares had fallen by 21.5% this
quarter and lost 25.3% so far this year.
* The company reported a quarterly loss of $3.8 million.
* Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $4.75 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 16 at 02:34 p.m.
 ​All figures in US dollars unless otherwise stated